CD14 and COVID-19: Representative dot-plots exemplify the contrast of CD14++CD16+ intermediate monocytes expressing IFN-alpha in whole blood samples exposed to polyclonal molecules from participants who experienced mild or severe COVID-19 throughout the follow-up (Figure 4D).